G20.B1

Clinical Causes: Progressive loss of dopamine-producing nerve cells in the brain Long-term use of Parkinson's medications, especially levodopa Genetic factors that may predispose individuals to the condition Age-related brain changes and environmental influences

Key Symptoms: Involuntary, writhing movements, often affecting the limbs, face, or trunk Muscle stiffness or rigidity Difficulty with precise movements and coordination Altered speech, with possible slurring or softer voice Reduced facial expressions (masked face) Postural instability or balance issues

Diagnosis Path: Diagnosing Parkinson's disease with dyskinesia involves a comprehensive clinical evaluation. Healthcare providers often review medical history, perform physical and neurological examinations, and assess motor symptoms. While there are no specific tests for Parkinson's, certain diagnostic criteria and ruling out other conditions help establish the diagnosis. The presence of dyskinesia, especially in relation to medication use, supports the diagnosis of this specific subtype. Advanced imaging techniques may sometimes be utilized to support the assessment, but they are not definitive.

Treatment Protocols: Adjusting medication regimens to reduce dyskinesia severity, such as modifying levodopa doses or timing Adding medications like amantadine, which can help reduce involuntary movements Considering non-pharmacological therapies, including physical and occupational therapy, to enhance mobility and coordination In some cases, surgical options like deep brain stimulation may be explored Lifestyle modifications, such as regular exercise and balanced nutrition, to support overall health